Aclarion ACON

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    -$0.23 (-14.37%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Aclarion (ACON)
    Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $1.38

    • Market Cap

      $1.40 Million

    • Price-Earnings Ratio

      -0.01

    • Total Outstanding Shares

      1.02 Million Shares

    • Total Employees

      6

    • Dividend

      No dividend

    • IPO Date

      April 22, 2022

    • SIC Description

      Services-medical Laboratories

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      8181 arista place, Broomfield, CO, 80021

    • Homepage

      https://www.aclarion.com

    Historical Stock Splits

    If you bought 5,360 shares of ACON before January 4, 2024, you'd have 1 share today.
    Execution DateSplit Amount
    January 30, 20251-for-335 (Reverse Split)
    January 4, 20241-for-16 (Reverse Split)

    Cash Flow Statement

    July 1, 2024 to September 30, 2024
    MetricValue
    Net Cash Flow, Continuing$139,410
    Net Cash Flow From Operating Activities, Continuing$-1.06 Million
    Net Cash Flow From Operating Activities$-1.06 Million
    Net Cash Flow From Financing Activities, Continuing$1.30 Million
    Net Cash Flow From Investing Activities, Continuing$-103,697
    Net Cash Flow$139,410

    Income Statement

    July 1, 2024 to September 30, 2024
    MetricValue
    Basic Earnings Per Share$-0.15
    Diluted Average Shares$9.44 Million
    Net Income/Loss Available To Common Stockholders, Basic$-1.38 Million
    Research and Development$195,797
    Operating Income/Loss$-1.30 Million
    Benefits Costs and Expenses$1.38 Million

    Comprehensive Income

    July 1, 2024 to September 30, 2024
    MetricValue
    Other Comprehensive Income/Loss$0
    Comprehensive Income/Loss$-1.38 Million
    Comprehensive Income/Loss Attributable To Parent$-1.38 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0

    Balance Sheet

    July 1, 2024 to September 30, 2024
    MetricValue
    Liabilities$678,267
    Accounts Payable$331,765
    Noncurrent Assets$1.29 Million
    Noncurrent Liabilities$0
    Current Liabilities$678,267
    Intangible Assets$1.29 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about ACON from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      â“’ 2025 Financhle. All Rights Reserved.